Press Releases

  Managed Health and PayChex Partner to Bring Companies a Unique Healthcare Solution

SALT LAKE CITY–(BUSINESS WIRE)–#costcontainment–Managed Health and PayChex, Inc. (NASDAQ: PAYX), a leading provider of integrated human capital management solutions for payroll, benefits, human resources, and insurance, announced a partnership to offer companies a new, unique, innovative healthcare solution. Managed Health…

READ REVIEWS  Managed Health and PayChex Partner to Bring Companies a Unique Healthcare Solution

Mitsui Chemicals showcases at FIND-DESIGN FAIR ASIA in Singapore new glass film, posica™ that improves view experience

TOKYO–(BUSINESS WIRE)–#FIND–Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) announced today that it will be exhibiting at the FIND-DESIGN FAIR ASIA, which is set to be held at Marina Bay Sands Convention Centre in Singapore over from 22…

READ REVIEWSMitsui Chemicals showcases at FIND-DESIGN FAIR ASIA in Singapore new glass film, posica™ that improves view experience

Crestwood Announces Pricing of Secondary Offering of Common Units and Concurrent Common Unit Repurchase

HOUSTON–(BUSINESS WIRE)–Crestwood Equity Partners LP (NYSE: CEQP) (“Crestwood”) today announced the pricing of the previously announced underwritten secondary offering by certain subsidiaries of Chord Energy Corporation (NASDAQ: CHRD) (f/k/a Oasis Petroleum Inc.) (the “Selling Unitholders”) of an aggregate of 11,400,000…

READ REVIEWSCrestwood Announces Pricing of Secondary Offering of Common Units and Concurrent Common Unit Repurchase

SEMA4 HOLDINGS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Sema4 Holdings Corp. – SMFR

NEW ORLEANS–(BUSINESS WIRE)–Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 7, 2022 to file lead plaintiff applications in a securities class action lawsuit…

READ REVIEWSSEMA4 HOLDINGS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Sema4 Holdings Corp. – SMFR

RA MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Ra Medical Systems, Inc. – RMED

NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Ra Medical Systems, Inc. (NYSE: RMED) (“the Company”) with Catheter Precision,…

READ REVIEWSRA MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Ra Medical Systems, Inc. – RMED

MEDTRONIC SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Medtronic plc – MDT

NEW ORLEANS–(BUSINESS WIRE)–Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 7, 2022 to file lead plaintiff applications in a securities class action lawsuit…

READ REVIEWSMEDTRONIC SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Medtronic plc – MDT

Revance Announces Pricing of $200.0 Million Upsized Public Offering of Common Stock

NASHVILLE, Tenn.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a commercial stage biotechnology company focused on innovative aesthetic and therapeutic offerings (“Revance” or the “Company”), today announced the pricing of an upsized underwritten public offering of 8,000,000 shares of its common stock.…

READ REVIEWSRevance Announces Pricing of $200.0 Million Upsized Public Offering of Common Stock